Completed NA INTERVENTIONAL 2-arm NCT03780933

the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS

The Impact of High Dose Vitamin C Ascorbic Acid on the Clinical Outcomes of Critically Ill Patients With Acute Respiratory Distress Syndrome

Sponsor: Misr International University

Conditions Acute Respiratory Distress

Interventions vitamin c

Updated 5 times since 2019 Last updated: Oct 1, 2019 Started: Jul 5, 2017 Primary completion: Jun 20, 2019 Completion: Jun 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Respiratory Distress and is currently completed. Misr International University leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2019 — Nov 2019 [monthly]

Recruiting NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Misr International University

Data source: Misr International University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt